Orlando, FL, United States of America

Adam Smith

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
2 patents (USPTO):

Title: Innovations by Adam Smith

Introduction

Adam Smith is a notable inventor based in Orlando, FL, who has made significant contributions to the field of pharmaceuticals. With a total of two patents to his name, he has focused on developing innovative compounds that have the potential to impact medical treatments.

Latest Patents

Smith's latest patents include groundbreaking work on gamma-hydroxybutyrate delivering compounds and processes for making and using them. This patent discloses compounds that comprise chemically modified gamma-hydroxybutyrate (GHB), 2-hydroxytetrahydrofuran, and/or 1,4-butanediol, along with their salts. The patent also outlines methods of treatment using these compounds. Another significant patent involves ketamine compounds and processes for making and using them. This invention details compounds that consist of ketamine chemically conjugated to various oxoacids, amino acids, and other compounds, along with methods for their production and application.

Career Highlights

Adam Smith is currently employed at Zevra Therapeutics, Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on developing new therapeutic compounds that can enhance treatment options for patients.

Collaborations

Some of his notable coworkers include Sven Guenther and Travis C Mickle, who collaborate with him on various projects within the company.

Conclusion

Adam Smith's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical science. His work has the potential to lead to significant improvements in treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…